Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$121.91M-9.0%$133.93M+0.6%$133.08M+4.2%$127.77M+4.5%$122.3M+4.3%
$45.91M-7.5%$49.65M-1.8%$50.54M-0.7%$50.91M-0.5%$51.14M+4.3%
$76M-9.8%$84.27M+2.1%$82.54M+7.4%$76.86M+8.0%$71.16M+4.3%
62.3%-0.6pp62.9%+0.9pp62%+1.9pp60.2%+2.0pp58.2%0.0pp
$2.09M-0.4%$2.1M-2.9%$2.17M-3.0%$2.23M-3.0%$2.3M-3.5%
$42.49M-6.6%$45.51M-1.6%$46.25M-0.3%$46.39M-3.3%$47.96M-2.6%
$28.12M-4.3%$29.38M+5.7%$27.78M-1.5%$28.2M-0.8%$28.44M-0.9%
$72.7M-5.6%$76.99M+1.0%$76.2M-0.8%$76.83M-2.4%$78.7M-2.0%
$6.35M+22,564%$28K+100%-$7.54M+37.5%
$3.23M-12.1%$3.67M-10.2%$4.09M-6.7%$4.38M+0.3%$4.37M+5.0%
-$4.09M+4.9%-$4.3M+1.4%-$4.36M-4.0%
$3.91M-44.2%$7M+210%$2.26M+153%-$4.27M+64.1%-$11.9M+26.8%
$2.08M+2.6%$2.03M+299%$508K+62.3%$313K+233%$94K-49.7%
$1.83M-63.3%$4.97M+184%$1.75M+138%-$4.58M+61.8%-$11.99M+27.1%
1.5%-2.2pp3.7%+2.4pp1.3%+4.9pp-3.6%+6.2pp-9.8%+4.2pp
$0.01-66.7%$0.03+200%$0.01+125%-$0.04+55.6%-$0.09+25.0%
$11.24M-28.7%$15.77M+44.7%$10.9M+143%$4.49M+238%-$3.25M+58.6%
9.2%-2.6pp11.8%+3.6pp8.2%+4.7pp3.5%+6.2pp-2.7%+4.0pp
$6.56M-37.8%$10.54M+66.2%$6.35M+22,564%$28K+100%-$7.54M+37.5%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Xtant Medical Holdings's revenue?
Xtant Medical Holdings (XTNT) generated $121.9M in revenue over the trailing twelve months, down 0.3% year over year.
Is Xtant Medical Holdings profitable?
Xtant Medical Holdings reported $1.8M in net income over the trailing twelve months, a 1.5% net margin.
What are Xtant Medical Holdings's profit margins?
Gross margin is 62.3% and operating margin is 4.8%, with a 1.5% net margin.
What is Xtant Medical Holdings's earnings per share?
Xtant Medical Holdings's diluted EPS over the trailing twelve months is $0.01.
Where does Xtant Medical Holdings's income statement data come from?
Every line is extracted from Xtant Medical Holdings's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.